Glucotrol XL 5mg Tablets

Manufacturer PFIZER Active Ingredient Glipizide Extended-Release Tablets(GLIP i zide) Pronunciation GLIP i zide
It is used to help control blood sugar in people with type 2 diabetes.
đŸˇī¸
Drug Class
Antidiabetic agent
đŸ§Ŧ
Pharmacologic Class
Sulfonylurea
🤰
Pregnancy Category
C
✅
FDA Approved
Sep 1994
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Glipizide extended-release is a medication used to help control high blood sugar (glucose) in people with type 2 diabetes. It works by helping your body release more insulin, a natural substance that helps move sugar from your blood into your cells for energy. This medication is taken once a day, usually with your first meal.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your dose with your first meal of the day. Swallow the tablet whole - do not chew, break, crush, or dissolve it. If you have a change in your eating habits or skip a meal, be sure to understand how to adjust your medication schedule accordingly.

Storing and Disposing of Your Medication

Keep your medication at room temperature in a dry place, avoiding storage in a bathroom. Store the medication in its original container to maintain its potency. Keep all medications in a safe location, out of the reach of children and pets, to prevent accidental ingestion.

Missing a Dose

If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for a missed dose.
💡

Lifestyle & Tips

  • Take Glipizide XL exactly as prescribed, usually once daily with breakfast or the first main meal.
  • Do not crush, chew, or divide the extended-release tablets; swallow them whole.
  • Follow a healthy diet plan recommended by your doctor or dietitian.
  • Engage in regular physical activity as advised by your healthcare provider.
  • Monitor your blood sugar levels regularly as instructed.
  • Carry a source of fast-acting sugar (e.g., glucose tablets, hard candy, fruit juice) to treat mild to moderate hypoglycemia.
  • Limit or avoid alcohol consumption, as it can affect blood sugar levels and increase the risk of hypoglycemia.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Initial: 5 mg orally once daily with breakfast or the first main meal. Maintenance: 5-20 mg orally once daily.
Dose Range: 5 - 20 mg

Condition-Specific Dosing:

type2Diabetes: Initial: 5 mg orally once daily with breakfast. Titrate in 2.5-5 mg increments at 3-7 day intervals based on blood glucose response. Max: 20 mg/day.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment required, but monitor closely.
Moderate: Use with caution; consider lower initial dose (e.g., 2.5 mg) and titrate slowly. Monitor closely for hypoglycemia.
Severe: Avoid use or use with extreme caution; significant risk of hypoglycemia. Consider alternative agents.
Dialysis: Not recommended due to prolonged half-life and risk of hypoglycemia. Insulin is generally preferred.

Hepatic Impairment:

Mild: Use with caution; consider lower initial dose (e.g., 2.5 mg) and titrate slowly. Monitor closely for hypoglycemia.
Moderate: Use with caution; consider lower initial dose (e.g., 2.5 mg) and titrate slowly. Monitor closely for hypoglycemia.
Severe: Avoid use or use with extreme caution due to increased risk of hypoglycemia. Consider alternative agents.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Glipizide, a second-generation sulfonylurea, lowers blood glucose primarily by stimulating the release of insulin from the beta cells of the pancreatic islets. It binds to the sulfonylurea receptor (SUR1) on the pancreatic beta-cell membrane, leading to the closure of ATP-sensitive potassium channels. This depolarizes the cell, opening voltage-gated calcium channels, and the influx of calcium triggers insulin secretion. It also has some extrapancreatic effects, including increased peripheral glucose utilization and decreased hepatic glucose production.
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 100%
Tmax: 2-3 hours (for ER formulation)
FoodEffect: Absorption is not significantly affected by food for the extended-release formulation, but it should be taken with breakfast or the first main meal to optimize blood glucose control.

Distribution:

Vd: Approximately 10-11 liters
ProteinBinding: Greater than 98% (primarily to albumin)
CnssPenetration: Limited

Elimination:

HalfLife: Approximately 10-14 hours (for ER formulation)
Clearance: Not readily available, primarily hepatic metabolism followed by renal excretion.
ExcretionRoute: Renal (approximately 80% as metabolites), Fecal (approximately 10% as metabolites)
Unchanged: Less than 1% (renal)
âąī¸

Pharmacodynamics

OnsetOfAction: 1-2 hours
PeakEffect: 6-12 hours
DurationOfAction: 24 hours

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Changes in eyesight
Slurred speech
Tingling
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling very tired or weak
Low blood sugar (hypoglycemia), which may be more likely when this medication is used with other diabetes medications. Symptoms of low blood sugar may include:
+ Dizziness
+ Headache
+ Feeling sleepy or weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating

If you experience any of these symptoms, contact your doctor right away. To manage low blood sugar, follow your doctor's instructions, which may include taking glucose tablets, liquid glucose, or some fruit juices.

Other Possible Side Effects

Like all medications, this drug can cause side effects. Although many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor or seek medical help:

Dizziness
Diarrhea
Feeling nervous and excitable
Gas

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Symptoms of low blood sugar (hypoglycemia): sweating, shaking, dizziness, confusion, hunger, irritability, headache, blurred vision, rapid heartbeat. If these occur, consume a fast-acting sugar source immediately.
  • Symptoms of high blood sugar (hyperglycemia): increased thirst, increased urination, fatigue, blurred vision (if medication is not working effectively).
  • Signs of allergic reaction: rash, itching, swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. Seek immediate medical attention.
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions to ensure safe treatment:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
A known sulfa allergy.
Any narrowing of the gastrointestinal (GI) tract or a history of bowel blockage.
Acidic blood problems, such as acidosis.
If you have type 1 diabetes, as this medication is not intended to treat this condition.

Additionally, this medication may interact with other health conditions or medications. Therefore, it is crucial to provide your doctor and pharmacist with a comprehensive list of:

All prescription and over-the-counter (OTC) medications you are taking.
Any natural products or vitamins you are using.
Your complete medical history, including any health problems.

Before starting, stopping, or changing the dose of any medication, including this one, consult with your doctor to confirm it is safe to do so. This will help prevent potential interactions or adverse effects.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Before engaging in activities that require alertness, such as driving, wait until you understand how this drug affects you. Monitor your blood sugar levels as instructed by your doctor.

Regular blood tests will be necessary, as directed by your doctor. Be sure to discuss any concerns or questions with your doctor during these appointments. Additionally, inform all healthcare providers and laboratory personnel that you are taking this medication, as it may impact certain lab test results.

Adhere to the diet and exercise plan recommended by your doctor. If you experience low blood sugar, avoid driving, as this can increase your risk of being involved in an accident. It is also recommended to avoid consuming alcohol while taking this medication.

If you are taking colesevelam, take it at least 4 hours after taking this drug. Be aware that stress, such as fever, infection, injury, or surgery, can affect blood sugar control. Changes in physical activity, exercise, or diet may also impact blood sugar levels.

Individuals with low levels of the enzyme G6PD should exercise caution, as they may be more prone to anemia. This enzyme deficiency is more common in patients of African, South Asian, Middle Eastern, and Mediterranean descent.

There is an increased risk of death from heart disease associated with this medication. Discuss this risk with your doctor. Low blood sugar is a potential side effect, and severe cases can lead to seizures, loss of consciousness, long-term brain damage, and even death. Consult your doctor if you have concerns about low blood sugar.

If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. Pregnant or breastfeeding women, or those planning to become pregnant, should discuss the benefits and risks of this medication with their doctor.

You may notice the tablet shell in your stool, but this is a normal occurrence and not a cause for concern. However, if you are taking this medication during pregnancy, you will need to stop taking it before your due date, as low blood sugar has been reported in infants born to mothers who took similar medications. Consult your doctor for guidance on managing this risk.
🆘

Overdose Information

Overdose Symptoms:

  • Severe hypoglycemia (extremely low blood sugar)
  • Confusion
  • Slurred speech
  • Tremor
  • Seizures
  • Loss of consciousness
  • Coma

What to Do:

Immediately consume a fast-acting sugar source (e.g., glucose tablets, sugar, honey, fruit juice). If the person is unconscious or unable to swallow, administer glucagon injection if available and call emergency medical services. Call 1-800-222-1222 (Poison Control Center) for further guidance.

Drug Interactions

🔴

Major Interactions

  • Bosentan (increased risk of hepatotoxicity)
  • Miconazole (oral, IV, topical - significantly enhances hypoglycemic effect)
  • Alcohol (acute ingestion can potentiate hypoglycemic effect; chronic ingestion can reduce it)
🟡

Moderate Interactions

  • Beta-blockers (mask symptoms of hypoglycemia, prolong recovery from hypoglycemia)
  • Fluconazole (increases glipizide levels, risk of hypoglycemia)
  • NSAIDs (e.g., ibuprofen, naproxen - may enhance hypoglycemic effect)
  • Salicylates (high doses - may enhance hypoglycemic effect)
  • Sulfonamides (may enhance hypoglycemic effect)
  • Chloramphenicol (may enhance hypoglycemic effect)
  • Coumarin derivatives (e.g., warfarin - may enhance hypoglycemic effect)
  • MAO inhibitors (may enhance hypoglycemic effect)
  • Probenecid (may enhance hypoglycemic effect)
  • Corticosteroids (decrease hypoglycemic effect)
  • Thiazide diuretics (decrease hypoglycemic effect)
  • Thyroid hormones (decrease hypoglycemic effect)
  • Sympathomimetics (e.g., decongestants - decrease hypoglycemic effect)
  • Phenytoin (decrease hypoglycemic effect)
  • Rifampin (decreases glipizide levels, reduces efficacy)
  • CYP2C9 inhibitors (e.g., amiodarone, fluoxetine, gemfibrozil, sulfinpyrazone - may increase glipizide levels and risk of hypoglycemia)
  • CYP2C9 inducers (e.g., carbamazepine, phenobarbital - may decrease glipizide levels and efficacy)
đŸŸĸ

Minor Interactions

  • Chromium (may enhance hypoglycemic effect)
  • Fenugreek (may enhance hypoglycemic effect)

Monitoring

đŸ”Ŧ

Baseline Monitoring

Fasting Plasma Glucose (FPG)

Rationale: To establish baseline glycemic control and confirm diagnosis of Type 2 Diabetes.

Timing: Prior to initiation of therapy.

Hemoglobin A1c (HbA1c)

Rationale: To establish baseline long-term glycemic control.

Timing: Prior to initiation of therapy.

Renal Function (e.g., eGFR, serum creatinine)

Rationale: To assess kidney function as glipizide and its metabolites are primarily renally excreted; dose adjustment may be needed in impairment.

Timing: Prior to initiation of therapy.

Hepatic Function (e.g., ALT, AST)

Rationale: To assess liver function as glipizide is extensively metabolized by the liver; dose adjustment may be needed in impairment.

Timing: Prior to initiation of therapy.

📊

Routine Monitoring

Fasting Plasma Glucose (FPG)

Frequency: Daily (patient self-monitoring) or as directed by physician

Target: 80-130 mg/dL (individualized)

Action Threshold: Below 70 mg/dL (hypoglycemia) or consistently above target range (hyperglycemia)

Postprandial Glucose (PPG)

Frequency: Periodically (patient self-monitoring) or as directed by physician

Target: <180 mg/dL (1-2 hours after meal, individualized)

Action Threshold: Consistently above target range

Hemoglobin A1c (HbA1c)

Frequency: Every 3-6 months

Target: <7.0% (individualized)

Action Threshold: Above target range (consider dose adjustment or additional therapy)

Signs and Symptoms of Hypoglycemia

Frequency: Continuously (patient education)

Target: N/A

Action Threshold: Presence of symptoms (e.g., sweating, tremor, confusion, hunger, dizziness) requires immediate action (consume fast-acting carbohydrates).

Renal Function (e.g., eGFR, serum creatinine)

Frequency: Annually or more frequently in patients with existing impairment or risk factors

Target: Stable within normal limits or acceptable range for patient's condition

Action Threshold: Significant decline in function (consider dose adjustment or discontinuation)

Hepatic Function (e.g., ALT, AST)

Frequency: Periodically, especially if signs of liver dysfunction or in patients with existing impairment

Target: Stable within normal limits

Action Threshold: Significant elevation (consider discontinuation)

đŸ‘ī¸

Symptom Monitoring

  • Symptoms of hypoglycemia: sweating, tremor, dizziness, confusion, hunger, irritability, headache, blurred vision, rapid heartbeat, anxiety, weakness, slurred speech, seizures, loss of consciousness.
  • Symptoms of hyperglycemia (if treatment is ineffective): increased thirst, increased urination, fatigue, blurred vision.

Special Patient Groups

🤰

Pregnancy

Glipizide is generally not recommended during pregnancy. Insulin is the preferred treatment for glycemic control in pregnant women with diabetes due to better safety data and lack of placental transfer concerns. If used, close monitoring of maternal and fetal blood glucose is essential.

Trimester-Specific Risks:

First Trimester: Potential for teratogenicity, though data are limited and conflicting. Insulin is preferred.
Second Trimester: Risk of fetal hypoglycemia if used close to delivery. Insulin is preferred.
Third Trimester: Increased risk of neonatal hypoglycemia if used near term, as sulfonylureas cross the placenta and stimulate fetal insulin release. Discontinue at least 2 weeks prior to expected delivery.
🤱

Lactation

Glipizide is excreted into breast milk and may cause hypoglycemia in the nursing infant. It is generally not recommended during breastfeeding. Insulin or other agents with better safety profiles during lactation are preferred.

Infant Risk: Risk of hypoglycemia in the breastfed infant. Monitor infant for signs of hypoglycemia (e.g., lethargy, poor feeding, jitteriness).
đŸ‘ļ

Pediatric Use

Safety and efficacy have not been established in pediatric patients. Not recommended for use in children.

👴

Geriatric Use

Elderly patients are more susceptible to the hypoglycemic effects of glipizide due to potential age-related decline in renal and hepatic function, and often have multiple comorbidities and polypharmacy. Start with lower doses (e.g., 2.5 mg) and titrate slowly with careful monitoring to avoid hypoglycemia. Avoid in frail elderly or those with frequent hypoglycemic episodes.

Clinical Information

💎

Clinical Pearls

  • Glipizide XL should be taken with breakfast or the first main meal of the day to ensure optimal absorption and glycemic control.
  • Do not crush, chew, or divide Glucotrol XL tablets, as this will destroy the extended-release mechanism and can lead to rapid absorption and potential hypoglycemia.
  • The 'ghost tablet' (empty shell) may be seen in the stool, which is normal and indicates the medication has been released.
  • Hypoglycemia is the most common and serious side effect. Educate patients on symptoms and how to treat it.
  • Patients should be advised to avoid or limit alcohol intake due to increased risk of hypoglycemia.
  • Consider alternative agents in patients with significant renal or hepatic impairment due to increased risk of prolonged hypoglycemia.
  • Weight gain is a common side effect associated with sulfonylureas.
🔄

Alternative Therapies

  • Metformin (first-line for most Type 2 Diabetes patients)
  • DPP-4 inhibitors (e.g., sitagliptin, saxagliptin)
  • SGLT2 inhibitors (e.g., empagliflozin, canagliflozin)
  • GLP-1 receptor agonists (e.g., liraglutide, semaglutide)
  • Thiazolidinediones (e.g., pioglitazone)
  • Insulin (various formulations)
  • Meglitinides (e.g., repaglinide, nateglinide - shorter acting insulin secretagogues)
  • Alpha-glucosidase inhibitors (e.g., acarbose)
💰

Cost & Coverage

Average Cost: $10 - $50 per 30 tablets (for generic 5mg ER)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (for generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe and effective treatment, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the overdose, including the medication taken, the amount, and the time it occurred.